Thursday, July 16, 2026

Yearly Archives: 2023

Code Ocean Partners with Nature Portfolio to Launch the Open Science Library with Ready-to-Run Software from Authors in Nature Journals

Code Ocean, the world's first Reproducible Research Cloud, announced that it has partnered with Nature Portfolio to launch a curated Open Science Library, containing research...

Trodelvy Demonstrates Positive Efficacy Treating Both Platinum-Ineligible and Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer

Gilead Sciences, Inc. announced new and updated positive results from three cohorts of the Phase 2 TROPHY-U-01 study of Trodelvy for the treatment of...

Adjuvant Opdivo (nivolumab) Continues to Provide Significant, Durable Clinical Benefits for Patients with Radically Resected, High-Risk Muscle-Invasive Urothelial Carcinoma After Three Years in CheckMate...

Bristol Myers Squibb announced three-year follow-up results from the Phase 3 CheckMate -274 trial, demonstrating significant sustained clinical benefits with Opdivo (nivolumab) for the adjuvant...

The Future is Electric: Why Electric Vehicles are the Way Forward

The world is changing rapidly, and with it, the way we think about transportation. One of the most significant changes in the automotive industry...

Breakthrough Discoveries in Human Immunology – Michelson Philanthropies and AAAS/Science Award Transformative Research

Michelson Philanthropies and AAAS/Science award Dr. Aleksandar Obradovic,of the Department of Systems Biology at Columbia University Irving Medical Center, with the 2023 Michelson Philanthropies & Science Prize for Immunology....
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics